Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts.


Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
10 2020
Historique:
received: 07 04 2020
revised: 03 06 2020
accepted: 05 06 2020
pubmed: 14 8 2020
medline: 22 12 2020
entrez: 14 8 2020
Statut: ppublish

Résumé

Pregnancy in women with lymphangioleiomyomatosis (LAM) has been associated with increased complications and worsening lung function although objective data to advise patients are not available. We assessed lung function and CT scans before and after pregnancy in 16 women with LAM. During the pregnancy, pneumothorax was frequent and mean forced expiratory volume in 1 s (FEV

Identifiants

pubmed: 32788260
pii: thoraxjnl-2020-214987
doi: 10.1136/thoraxjnl-2020-214987
pmc: PMC10009819
mid: NIHMS1866775
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

904-907

Subventions

Organisme : Intramural NIH HHS
ID : Z01 HL002541
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: SRJ received grant funding from the NIHR-RDTRC for the current work.

Références

Thorax. 2000 Dec;55(12):1052-7
pubmed: 11083892
Chest. 2004 Dec;126(6):1867-74
pubmed: 15596686
Chest. 2019 May;155(5):962-971
pubmed: 30660784
Eur Respir J. 2019 Apr 4;53(4):
pubmed: 30846465
J Clin Invest. 2012 Nov;122(11):3807-16
pubmed: 23114603
Am J Respir Crit Care Med. 1999 Aug;160(2):628-33
pubmed: 10430739
J Reprod Med. 1987 Jul;32(7):553-7
pubmed: 3625622
Eur Respir J. 2018 Apr 19;51(4):
pubmed: 29519926
Eur Respir J. 2010 Jan;35(1):14-26
pubmed: 20044458
Respir Med. 2009 May;103(5):766-72
pubmed: 19117742

Auteurs

Angelo M Taveira-DaSilva (AM)

Cardiovascular and Pulmonary Branch/NHLBI, NIH, Bethesda, Maryland, USA.

Simon R Johnson (SR)

Respiratory Medicine, University of Nottingham, NIHR Biomedical Research Centre, Nottingham Biodiscovery Institute and National Centre for LAM, Nottingham, UK simon.johnson@nottingham.ac.uk.

Patricia Julien-Williams (P)

Cardiovascular and Pulmonary Branch/NHLBI, NIH, Bethesda, Maryland, USA.

Jan Johnson (J)

Respiratory Medicine, University of Nottingham Faculty of Medicine and Health Sciences, Nottingham, Nottingham, UK.

Mario Stylianou (M)

National Heart, Lung, and Blood Institute, Office of Biostatistics Research, National Institutes of Health, Bethesda, Maryland, USA.

Joel Moss (J)

Translational Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Hea, Bethesda, Maryland, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH